Does Naltrexone Treatment Lead to Depression? Findings From a Randomized Controlled Trial in Subjects With Opioid Dependence (Abstract)

J Psychiatry Neurosci
January 2006
https://pubmed.ncbi.nlm.nih.gov/16496034/

Objective: Dysphoria and depression have been cited as side effects of the opioid antagonist naltrexone. We aimed to assess whether depressive symptoms are a clinically relevant side effect in a population receiving naltrexone as a treatment for opioid dependence.

Low Dose Naltrexone in the Treatment of Fibromyalgia (Abstract)

Curr Rheumatol Rev
2018
https://pubmed.ncbi.nlm.nih.gov/28325149/

Background: ConclusionFibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleep disturbance and cognitive impairment.

Naltrexone could alleviate depression symptoms in patients who relapsed while taking antidepressants

PsyPost
18 December 2016
https://www.psypost.org/2016/12/naltrexone-alleviate-depression-symptoms-patients-relapsed-taking-antidepressants-46566

The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice

Low dose naltrexone in the treatment of dissociative symptoms (article in German)

Nervenarzt
March 2015
https://pubmed.ncbi.nlm.nih.gov/25421416/

Background: Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day).

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis

BMC Medicine
15 January  2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0

Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine - a case report

Psychopharmacology (Berl)
April 1999
https://www.researchgate.net/publication/227273768_Resolution_of_treatment-refractory_depression_with_naltrexone_augmentation_of_paroxetine_-_A_case_report

Galyn Forster, MS, LP - Treating Psychiatric Disorders with LDN Case Studies (2019 Conference) (LDN, low dose naltrexone)

Galyn Forster's case studies include: Traumatic stress disorder, dissociative disorder, anxiety, phobia, pain and hypervigilance

The Neuropsychoanalytic Approach: Using Neuroscience as the Basic Science of Psychoanalysis

Front Psychol
Oct 2016
https://pubmed.ncbi.nlm.nih.gov/27790160/